Arcturus Therapeutics, Catalent Announce Partnership To Manufacture Covid-19 Vaccine

Arcturus Therapeutics, Catalent Announce Partnership To Manufacture Covid-19 Vaccine

Source: 
Reuters
snippet: 

Arcturus Therapeutics and Catalent have announced a partnership to manufacture an mRNA-based vaccine for COVID-19.